性饮食和与代谢功能障碍相关的脂肪性肝病:文献综述
Kexin Sun1, Weitian Li2, Yunan Chen3
1School of Medicine, The Chinese University of Hong Kong Shenzhen, Guangdong, 518172, People's Republic of China.
Cell & bioscience
|December 14, 2025
概括
性饮食显示出对管理代谢功能障碍相关的脂肪性肝病 (MASLD) 的承诺. 短期使用可以改善肝脏脂肪和降低甘油三,可能超过低脂肪饮食.
科学领域:
- 营养科学 营养科学
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 影响全球超过30%,增加代谢疾病的风险.
- 饮食干预对于MASLD的预防和管理至关重要.
- 性饮食,碳水化合物非常低,诱导营养症,并被探索MASLD的好处.
研究的目的:
- 审查目前关于MASLD患者食结果的研究结果.
- 评估对肝脏健康,脂质样本,炎症和肠道微生物群的影响.
主要方法:
- 审查关于性饮食和MASLD的现有研究.
- 对肝硬化症,肝硬化性肝炎,纤维化,血脂质,炎症和肠道微生物群的影响分析.
主要成果:
- 短期到中期的性饮食可以降低甘油三,改善MASLD中的肝硬化,肝硬化和纤维化.
- 性饮食可能比低脂肪饮食更有效,可以在短期内缓解肝肥胖症.
- 关于HDL-c和LDL-c的证据是混合的;关于全身炎症和肠道微生物群的数据有限.
结论:
- 性饮食对MASLD管理有潜在的好处,特别是在短期内.
- 需要长期的受控试验来澄清益处,风险和最佳配方.
- 进一步的研究应该调查对全身炎症和肠道微生物群组成的影响.
相关概念视频
Overview of Lipid Metabolism
4.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.7K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Inborn Errors of Metabolism
681
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
681
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
200
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
200
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
Liver Physiology
3.4K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.4K


